Aclaris Therapeutics ATI-2138 Phase 2a Results and ITK Franchise Update | Aclaris Therapeutics, Inc.

View all events »

Aclaris Therapeutics ATI-2138 Phase 2a Results and ITK Franchise Update

Jul 29, 2025
5:00 PM EDT

Click here for webcast

Supporting Materials

ATI-2138 Phase 2a Top-Line Results 1.6 MB